http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Biomarkers for agrochemicals and toxic substances
xii, 282 pages : illustrations, map ; 24 cm.
Relationship of biomarkers of exposure to risk assessment and risk management -- Proposed use of human exposure biomarkers in environmental legislation : toxic substances control act -- The use of reference range concentrations in environmental health investigations -- Possible biomarkers for assessing health risks in susceptible individuals exposed to agrochemicals with emphasis on developing countries -- Blood cholinesterase activity : inhibition as an indicator of adverse effect -- Neurotoxic esterase inhibition : Predictor of potential for organophosphorus-induced delayed neuropathy -- Increased urinary excretion of Xanthurenic acid as a biomarker of exposure to organophosphorus insecticides -- Serum protein profile : a possible biomarker for exposure to insecticides -- Breast milk as a biomarker for monitoring human exposure to environmental pollutants -- Carnitine and its esters as potential biomarkers of environmental- toxicological exposure to nongenotoxic tumorigens -- L-Carnitine as a detoxicant of nonmetabolizable acyl coenzyme A -- The use of human 101L cells as a biomarker, P450 RGS, for assessing the potential risk of environmental samples -- Field application of fluorescence- based catalytic assays for measuring cytochrome P450 induction in birds -- Initial results for the inductively coupled plasma- mass spectrometric determination of trace elements in organs of striped bass from Lake Mead, U.S.A. -- Aquatic toxicity of chemical agent simulants as determined by quantitative structure- activity relationships and acute bioassays -- Use of multiple pathway and multiroute physiologically based pharmacokinetic model for predicting organophosphorus pesticide toxicity -- Use of spot urine sample results in physiologically based pharmacokinetic modeling of absorbed malathion doses in humans -- Symbolic solutions of small linear physiologically based pharmacokinetic models useful in risk assessment and experimental design -- Comparison of symbolic, numerical area under the concentration curves of small linear physiologically based pharmacokinetic models
Developed from a symposium sponsored by the Division of Agrochemicals.
Includes bibliographical references and indexes.